The COVID Vaccine Pause: A Case for Greater Patient Engagement

The COVID Vaccine Pause: A Case for Greater Patient Engagement

Posted May 24, 2021 from
Community%20of%20Practice/Join/green?scale=1.5


Despite initial concerns that the pause might fuel vaccine hesitancy and delay getting shots in arms of at-risk populations, the drug’s hiatus may have saved lives. In several early cases of J&J vaccine blood clotting, patients were treated with heparin, which is a normal treatment for blood clots; however, in these cases the heparin worsened the situation. The pause helped educate hospitals and health systems going forward on how to treat similar symptoms in those with the J&J dose.

To get in front of the situation, practices needed to quickly alert patients about the pause, address health concerns from patients who had already received the J&J shot, and help patients reschedule. It was only through rapid communication that providers could proactively resolve patient concerns, calm fears, and offer guidance.

Continue reading at

Did you find this useful? Like

See Topics


Next Article